Multiple Myeloma: What Is the Risk Stratification?

Smoldering myeloma likely won't be tested because it's category 2B. Clinical trials are preferred in this setting. Some institutions may select two years of lenalidomide with dexamethasone for those who have that high-risk 220-20 features.